フォロー
Motoki Fujimaki
Motoki Fujimaki
所属不明
確認したメール アドレス: juntendo.ac.jp
タイトル
引用先
引用先
The different autophagy degradation pathways and neurodegeneration
A Fleming, M Bourdenx, M Fujimaki, C Karabiyik, GJ Krause, A Lopez, ...
Neuron 110 (6), 935-966, 2022
3002022
Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease
S Saiki, T Hatano, M Fujimaki, KI Ishikawa, A Mori, Y Oji, A Okuzumi, ...
Scientific reports 7 (1), 7328, 2017
1392017
A metabolic profile of polyamines in parkinson disease: A promising biomarker
S Saiki, Y Sasazawa, M Fujimaki, K Kamagata, N Kaga, H Taka, Y Li, ...
Annals of neurology 86 (2), 251-263, 2019
1072019
Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
M Fujimaki, S Saiki, Y Li, N Kaga, H Taka, T Hatano, KI Ishikawa, Y Oji, ...
Neurology 90 (5), e404-e411, 2018
1052018
Iron supply via NCOA4-mediated ferritin degradation maintains mitochondrial functions
M Fujimaki, N Furuya, S Saiki, T Amo, Y Imamichi, N Hattori
Molecular and Cellular Biology 39 (14), e00010-19, 2019
732019
Neuroprotective effects of memantine via enhancement of autophagy
K Hirano, M Fujimaki, Y Sasazawa, A Yamaguchi, KI Ishikawa, ...
Biochemical and biophysical research communications 518 (1), 161-170, 2019
562019
Metabolomics‐based identification of metabolic alterations in PARK2
A Okuzumi, T Hatano, SI Ueno, T Ogawa, S Saiki, A Mori, T Koinuma, ...
Annals of Clinical and Translational Neurology 6 (3), 525-536, 2019
522019
Mendelian neurodegenerative disease genes involved in autophagy
E Stamatakou, L Wróbel, SM Hill, C Puri, SM Son, M Fujimaki, Y Zhu, ...
Cell discovery 6 (1), 24, 2020
452020
Huntingtin-lowering strategies for Huntington’s disease
RA Barker, M Fujimaki, P Rogers, DC Rubinsztein
Expert opinion on investigational drugs 29 (10), 1125-1132, 2020
342020
Non-invasive diagnostic tool for Parkinson’s disease by sebum RNA profile with machine learning
Y Uehara, SI Ueno, H Amano-Takeshige, S Suzuki, Y Imamichi, ...
Scientific reports 11 (1), 18550, 2021
262021
Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease
SI Ueno, T Hatano, A Okuzumi, S Saiki, Y Oji, A Mori, T Koinuma, ...
Annals of Clinical and Translational Neurology 7 (3), 307-317, 2020
262020
Acute psychosis as an initial manifestation of hypothyroidism: a case report
S Ueno, S Tsuboi, M Fujimaki, H Eguchi, Y Machida, N Hattori, H Miwa
Journal of Medical Case Reports 9, 1-3, 2015
262015
Shared metabolic profile of caffeine in Parkinsonian disorders
H Takeshige‐Amano, S Saiki, M Fujimaki, SI Ueno, Y Li, T Hatano, ...
Movement Disorders 35 (8), 1438-1447, 2020
192020
Demyelinating peripheral neuropathy due to renal cell carcinoma
K Nishioka, M Fujimaki, K Kanai, Y Ishiguro, T Nakazato, R Tanaka, ...
Internal Medicine 56 (1), 101-104, 2017
122017
Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy
A Mori, KI Ishikawa, S Saiki, T Hatano, Y Oji, A Okuzumi, M Fujimaki, ...
PLoS One 14 (9), e0223113, 2019
112019
Zonisamide administration improves fatty acid β-oxidation in Parkinson’s disease
SI Ueno, S Saiki, M Fujimaki, H Takeshige-Amano, T Hatano, G Oyama, ...
Cells 8 (1), 14, 2018
112018
Immunocytochemical monitoring of PINK1/Parkin-mediated mitophagy in cultured cells
M Fujimaki, S Saiki, Y Sasazawa, KI Ishikawa, Y Imamichi, K Sumiyoshi, ...
Mitophagy: Methods and Protocols, 19-27, 2018
102018
Lymphomatoid granulomatosis with central nervous system involvement successfully treated with cyclophosphamide, high‐dose Cytarabine, dexamethasone, Etoposide, and rituximab …
M Fujimaki, S Kawajiri, K Ichikawa, Y Tomizawa, T Nakazato, K Noda, ...
CNS Neuroscience & Therapeutics 21 (7), 610, 2015
102015
Systemic metabolic alteration dependent on the thyroid‐liver axis in early PD
K Miyamoto, S Saiki, H Matsumoto, A Suzuki, Y Yamashita, T Iseki, ...
Annals of Neurology 93 (2), 303-316, 2023
92023
Loss of WIPI4 in neurodegeneration causes autophagy-independent ferroptosis
Y Zhu, M Fujimaki, L Snape, A Lopez, A Fleming, DC Rubinsztein
Nature Cell Biology 26 (4), 542-551, 2024
82024
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20